Literature DB >> 21741667

Nucleocytoplasmic shuttling of the HSV-2 serine/threonine kinase Us3.

Renée L Finnen1, Susan M Johnston, Casey E Neron, Bruce W Banfield.   

Abstract

The alphaherpesvirus serine/threonine kinase Us3 plays diverse roles in virus multiplication and modifies both nuclear and cytoplasmic substrates. We recently reported that treatment of HSV-2 Us3-transfected and HSV-2-infected cells with leptomycin B, an inhibitor of nuclear export mediated by interaction of chromosomal regional maintenance protein (CRM1) with leucine rich nuclear export signals (NESs), resulted in nuclear trapping of Us3. Here, we utilized fluorescence loss in photobleaching to monitor nuclear export of HSV-2 Us3 and confirm that this process proceeds solely via a CRM1-mediated mechanism. Analysis of deletion derivatives of HSV-2 Us3 fused to a nuclear export reporter protein implicated the involvement of NES-like sequences in nuclear export. However, nuclear trapping of HSV-2 Us3 proteins carrying mutations in these potential NESs was not observed, indicating that these sequences are not functional in the context of full-length protein. Our analyses also revealed previously unidentified regions of HSV-2 Us3 that contribute to its kinase activity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741667      PMCID: PMC3152661          DOI: 10.1016/j.virol.2011.06.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins.

Authors:  J Munger; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 2.  Regulation of p53 localization.

Authors:  S H Liang; M F Clarke
Journal:  Eur J Biochem       Date:  2001-05

Review 3.  Nuclear export of ribosomal subunits.

Authors:  Arlen W Johnson; Elsebet Lund; James Dahlberg
Journal:  Trends Biochem Sci       Date:  2002-11       Impact factor: 13.807

4.  Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids.

Authors:  Ashley E Reynolds; Elizabeth G Wills; Richard J Roller; Brent J Ryckman; Joel D Baines
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  NESbase version 1.0: a database of nuclear export signals.

Authors:  Tanja la Cour; Ramneek Gupta; Kristoffer Rapacki; Karen Skriver; Flemming M Poulsen; Søren Brunak
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 6.  Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses.

Authors:  Jerome F Cros; Peter Palese
Journal:  Virus Res       Date:  2003-09       Impact factor: 3.303

7.  Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene.

Authors:  S Hata; A H Koyama; H Shiota; A Adachi; F Goshima; Y Nishiyama
Journal:  Microbes Infect       Date:  1999-07       Impact factor: 2.700

8.  The alphaherpesvirus serine/threonine kinase us3 disrupts promyelocytic leukemia protein nuclear bodies.

Authors:  Masany Jung; Renée L Finnen; Casey E Neron; Bruce W Banfield
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

9.  Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection.

Authors:  G L Demmin; A C Clase; J A Randall; L W Enquist; B W Banfield
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Herpes simplex virus 1 gene expression is accelerated by inhibitors of histone deacetylases in rabbit skin cells infected with a mutant carrying a cDNA copy of the infected-cell protein no. 0.

Authors:  Alice P W Poon; Yu Liang; Bernard Roizman
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.